task
0 (0 Likes / 0 Dislikes)
Hello people, I want to talk to you
about covid-19 vaccine, okey?
The one developed by University of
Oxford together with AstraZeneca
to said company, all right? Recently
the published the results for so the
overall efficiency of the vaccine
and this... the number was 70%
Now, compared to the other two, with
numbers in the ratio of 90-95% this
look bad. However, it turn out they
made a mistake with about three
thousand people volunteers and...
because they gave to this people a
low at dose regime of the vaccine,
so basically they gave the same
amount of liquid but the was less
amount of vaccine in the liquid, it
was deleted. So, this was a mistake!
Every turn out! Then, when you do
that in the first dose and then you
give the full of mount in the second,
it looks like the overall efficacy
rises from 70 to round 90%. Now,
taking into account that this vaccine
cheaper that the other two, it's in
the ratio of to three euros around
and... 20 whatever. And then can be
stored in freezers, all right? At
freeze temperature around eight
degrees positive, rather minus 20
minus 80. So, of course, this...
that all this too characteristics
make this vaccine much better, so
the only problem would be the lower
efficacy. But, if turns out that the
overall efficacy is actually in the
ratio of 90%... then that's really
good. So, looks like they're going
to make new trials now. But then,
of course, some people are saying:
Ah, if they're making new ones is
because they didn't doing right the
first time in someone. So it's tricky.